Top-line Results From MaGic, a Phase Two Trial of Claseprubart (DNTH103), an Active C1s Inhibitor, in Generalized Myasthenia Gravis

Native Methylation Sequencing for Detection and Monitoring of Alzheimer’s Disease, Parkinson’s and ALS

MS4A6A/Ms4a6d Deficiency Disrupts Neuroprotective Microglia Functions and Promotes Inflammation in Alzheimer’s Disease Model

Preclinical Tau Deposition is Associated with Reduction of the DMN Deactivation During Episodic Memory Tasks